Penserra Capital Management LLC Nkarta, Inc. Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$12.79 - $26.88 $9,656 - $20,294	-755 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$26.67 - $38.76 $266 - $387	10 Added 1.34%	755 $20,000
Q2 2021 Aug 12, 2021	BUY	$23.94 - $36.68 $119 - $183	5 Added 0.68%	745 $23,000
Q1 2021 May 13, 2021	SELL	$31.33 - $59.61 $313 - $596	-10 Reduced 1.33%	740 $24,000
Q4 2020 Feb 12, 2021	BUY	$27.03 - $75.62 $20,272 - $56,715	750 New	750 $46,000

129

66.5M

173K

20K

Ticker NKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,656,800
Market Cap $127M
Description
Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.